Sustainable Packaging Innovation
Developing pharmaceutical packaging solutions that reduce environmental impact while maintaining the product protection, regulatory compliance, and patient safety that our customers require.
INNOVATION
Sustainability Within Regulatory Reality
Sustainable packaging innovation in pharmaceuticals operates under constraints that do not exist in consumer goods or food packaging. Every change to a pharmaceutical package - whether it involves a different material, a different structure, or a different manufacturing process - must be validated against regulatory requirements, stability protocols, and patient safety standards. Child-resistant closures, moisture barriers, light protection, oxygen barriers, and tamper evidence are not optional features. They are regulatory requirements that protect patients.
This means that the path to more sustainable pharmaceutical packaging is not simply a matter of switching to recycled or recyclable materials. It requires careful engineering, extensive testing, regulatory review, and close collaboration between the packaging manufacturer, the pharmaceutical company, and often the regulatory agency itself. Progress is incremental, but it is real and it is accelerating.
Meridan is committed to being a proactive partner in this work. We bring deep knowledge of pharmaceutical packaging materials, regulatory requirements, and manufacturing processes - and we apply that knowledge to help our customers identify packaging improvements that deliver genuine environmental benefits without creating compliance risks or compromising patient safety.
STRATEGY
Focus Areas
Our sustainable packaging work spans four interconnected areas, each contributing to reduced environmental impact across the packaging life cycle.
Material Optimization
Reducing the total amount of material used in pharmaceutical packaging without compromising product protection or regulatory compliance.
- Lightweighting programs that reduce film gauge, foil thickness, and carton board weight while maintaining barrier properties and structural integrity
- Right-sizing initiatives that match packaging dimensions to actual product requirements, eliminating unnecessary void space and excess material
- Design optimization using finite element analysis and structural simulation to identify where material can be removed without affecting performance
- Standardization of packaging formats across product families to reduce tooling variety and improve material utilization rates
- Collaboration with material suppliers to develop thinner, higher-performance substrates that deliver equivalent protection with less raw material
Recyclable Material Alternatives
Evaluating and qualifying packaging materials that are more readily recyclable at end of life, while meeting the demanding barrier and regulatory requirements of pharmaceutical applications.
- Mono-material blister systems that replace multi-layer PVC/PVdC/aluminum constructions with single-polymer structures that are compatible with existing recycling infrastructure
- Recyclable film alternatives for thermoform and cold-form blister packaging, including evaluation of polypropylene-based and polyester-based substitutes
- Paper-based packaging alternatives for secondary packaging applications where moisture, light, and oxygen barriers are not critical requirements
- Water-based adhesive and coating systems that replace solvent-based alternatives, improving both recyclability and reducing hazardous waste from manufacturing
- Evaluation of bio-based and compostable materials for non-patient-facing packaging components such as instruction leaflets, desiccant packets, and inner separators
Reducing Packaging Waste in the Supply Chain
Optimizing secondary and tertiary packaging to reduce material waste, transportation emissions, and disposal burden throughout the pharmaceutical distribution chain.
- Secondary packaging optimization to minimize the size and weight of cartons, shippers, and display packaging without affecting retail shelf requirements or logistics handling
- Tertiary packaging redesign to increase pallet density, reduce stretch wrap usage, and improve cube utilization in transportation
- Returnable and reusable shipper programs for high-volume distribution routes where closed-loop logistics are practical
- Elimination of unnecessary packaging layers and components through systematic packaging line analysis
- Coordination with logistics partners to align packaging specifications with transportation requirements, avoiding overpackaging driven by uncertainty about handling conditions
Life Cycle Assessment
Building capabilities to evaluate the full environmental impact of packaging design choices, from raw material extraction through end-of-life disposal.
- Developing internal life cycle assessment capabilities to compare the environmental impact of alternative packaging designs across key metrics including carbon footprint, water usage, and waste generation
- Building a database of environmental impact factors for commonly used pharmaceutical packaging materials, enabling rapid comparative assessments during the packaging design process
- Partnering with material suppliers to obtain Environmental Product Declarations and cradle-to-gate emissions data for packaging inputs
- Integrating environmental impact data into the packaging design decision process alongside cost, compliance, and performance criteria
- Providing customers with packaging environmental profiles that support their Scope 3 reporting and sustainable procurement goals
COLLABORATION
Customer Collaboration
The most impactful sustainable packaging improvements emerge from close collaboration between Meridan and our pharmaceutical customers. Every product has unique requirements for stability, protection, regulatory compliance, and supply chain handling - and sustainable alternatives must be evaluated within that specific context. A packaging change that works for a solid oral dosage form may not be viable for a biologic, and vice versa.
Meridan works with customers at every stage of the sustainable packaging development process: identifying opportunities for material reduction or substitution, sourcing and qualifying alternative materials, conducting compatibility and stability testing, supporting regulatory submissions, and validating new packaging configurations on our production lines. We treat sustainable packaging as an engineering challenge, not a marketing exercise.
We also recognize that sustainable packaging decisions must balance multiple competing priorities. Customers need packaging that protects the product, meets all regulatory requirements including child-resistance and tamper evidence, performs reliably at high speeds on automated packaging lines, satisfies supply chain and distribution requirements, and does all of this at a competitive cost. Environmental improvement is a critical additional lens, but it must be integrated with these existing requirements rather than treated in isolation.
Regulatory Considerations
Any change to the primary packaging of a pharmaceutical product may require a regulatory filing, stability study, or formal change control process. Meridan's quality and regulatory affairs team works closely with customers to navigate these requirements, ensuring that sustainable packaging transitions are executed within the appropriate regulatory framework. This includes evaluating whether a proposed material change constitutes a minor change, a moderate change, or a prior approval supplement under applicable FDA guidelines, and supporting customers through the documentation and submission process.
Sustainable Packaging Inquiries
Interested in evaluating sustainable packaging alternatives for your pharmaceutical products? Our packaging engineers can help.